February 24 - 14:02
Truvian Sciences nabs $105 million for blood-testing tech
Truvian Sciences has completed a huge Series C funding round. The company's automated benchtop blood-testing technology has proven popular with investors, who backed Truvian to the tune of $105m. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and Wittington Ventures. Truvian says it will now grow its product development team around the automation piece.
> Tweets